Clinical Trials Browser

Breast Neoplasms, Patient Preference, Inflammatory Breast Neoplasms

NCT01723774 2025-12-09

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

Phase 2 Active not recruiting

84 enrolled 17 charts

Breast

Breast Neoplasms

NCT02364557 2025-10-15

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

Phase 2/3 Completed

129 enrolled 23 charts

Breast

Breast Neoplasms, Lymphatic Metastasis

NCT02807597 2025-08-17

Real-time Intraoperative Breast Cancer Visualization for Margin Assessment

Phase 1/2 Terminated

9 enrolled 5 charts

Breast

Breast Neoplasms

NCT04109066 2025-01-08

CheckMate 7FL

Phase 3 Completed

521 enrolled 17 charts

Breast

Breast Neoplasms, Neoplasms

NCT00182728 2024-10-01

NRR

Phase NA Completed

89 enrolled 10 charts

Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT01015625 2024-08-19

POSYTIVE

Phase NA Completed

90 enrolled 16 charts

Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT03493854 2024-06-26

FeDeriCa

Phase 3 Completed

500 enrolled 28 charts 3 FDA

Breast

Breast Neoplasms

NCT02586025 2023-05-22

PEONY

Phase 3 Completed

329 enrolled 33 charts

Breast

Breast Neoplasms

NCT03916744 2023-03-10

A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer

Phase 1 Completed

75 enrolled 24 charts

Breast

Breast Neoplasms

NCT04436744 2023-02-02

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

Phase 2 Completed

221 enrolled 21 charts

Breast

Breast Neoplasms

NCT01847001 2021-09-10

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Phase 2 Completed

10 enrolled 12 charts

Breast

Breast Neoplasms

NCT00574587 2020-10-14

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Phase 1/2 Completed

55 enrolled 10 charts

Breast

Breast Neoplasms

NCT00262834 2020-02-19

Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer

Phase 2 Completed

54 enrolled 7 charts

Breast

Breast Neoplasms

NCT00675259 2018-07-24

Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer

Phase 2 Completed

33 enrolled 10 charts

Breast

Breast Neoplasms

NCT01388777 2018-07-17

Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy

Phase 2 Terminated

1 enrolled 4 charts

Breast

Breast Neoplasms

NCT00944047 2018-04-23

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

Phase 2 Completed

32 enrolled 7 charts

Breast

Breast Neoplasms

NCT00450723 2017-02-07

Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer

Phase NA Completed

39 enrolled 6 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01368263 2015-04-03

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

Phase 2 Terminated

8 enrolled 5 charts

Breast

Breast Neoplasms

NCT00849472 2014-03-04

Treatment With Pazopanib for Neoadjuvant Breast Cancer

Phase 2 Completed

101 enrolled 16 charts

Breast

Breast Neoplasms

NCT00191789 2010-07-27

Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer

Phase 2 Completed

65 enrolled 13 charts

Breast

Breast Neoplasms

Clinical Trials

ProHer

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

Real-time Intraoperative Breast Cancer Visualization for Margin Assessment

CheckMate 7FL

NRR

POSYTIVE

FeDeriCa

PEONY

A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer

Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer

Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

Treatment With Pazopanib for Neoadjuvant Breast Cancer

Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer